UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
FORM 8-K
----------------
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
January 10, 2007
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Commission File No. 0-21116
Utah 87-0500306
(State or other jurisdiction (IRS Employer Identification
of incorporation) Number)
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801) 954-7100
Former name or former address, if changed since last report: Not Applicable
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On January 10, 2007, USANA Health Sciences, Inc. issued a press release
announcing its preliminary financial results for the fourth quarter ended
December 30, 2006. The release also announced that the Company plans to release
its final fourth quarter and full year 2006 results on February 6, 2007. A copy
of the press release is furnished herewith as Exhibit 99 to this Current Report
on Form 8-K and is incorporated herein by reference. The company will also post
this document on its corporate website, www.usanahealthsciences.com.
The information in this Item 2.02 is being furnished and shall not be deemed
"filed" for the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that Section. The
information in this Current Report shall not be incorporated by reference into
any registration statement or other document pursuant to the Securities Act of
1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
available.
Item 8.01 Other Events
The Company also announced in the January 10, 2007 press release that it has
commenced operations in Malaysia and began accepting applications and processing
orders there on January 8, 2007.
Additionally, the Company announced that it will make an immaterial
reclassification to its consolidated financial statements beginning with the
fourth quarter 2006. This reclassification will not affect reported operating
earnings, net earnings, or earnings per share. However, this reclassification
will reduce net sales by approximately 1.5%, offset by a corresponding reduction
in Associate incentive expense. The Company provided historical financial tables
that include both pre and post-reclassification data for the quarterly periods
for fiscal years 2004, 2005, and for the nine months ended September 30, 2006.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99 Press release issued by USANA Health Sciences, Inc. dated
January 10, 2007 (furnished herewith).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
USANA HEALTH SCIENCES, INC.
By: /s/ Gilbert A. Fuller
-----------------------
Gilbert A. Fuller,
Chief Financial Officer
Date: January 10, 2007
3